Sarcoma  >>  Oraxol (oral paclitaxel/encequidar)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Oraxol (oral paclitaxel/encequidar) / Athenex
2019-002085-13: A Pilot Study of Oraxol in Subjects with Cutaneous Angiosarcoma

Not yet recruiting
2
43
Europe
Oraxol, HM30181AK-US, paclitaxel capsules, Tablet, Capsule, hard
Athenex, Inc, Athenex, Inc
Study of Oraxol in Subjects with Cutaneous Angiosarcoma, Soft tissue sarcoma, Diseases [C] - Cancer [C04]
 
 
KX-ORAX-010 , NCT03544567: A Study of Oraxol in Subjects With Cutaneous Angiosarcoma

Completed
2
48
Europe, US, RoW
Oraxol, oral HM30181A + oral paclitaxel
Athenex, Inc.
Angiosarcoma of Skin
05/23
05/23

Download Options